Table 2. Scabies-related episode characteristics between 2014 and 2023.

	2014–2020a			2021–2023
	n	%	per 100 000 patient-years	n	%	per 100 000 patient-years	P-value
Reason for encounter							<0.001
Prevention, risk factor, or medication request (A98, A23, *50)	87	22.7	33	351	35.1	290	d
Scabies (S72)	84	21.9	32	332	33.2	274	d
Itch (S02)	110	28.7	42	143	14.3	118	d
Other	102	26.6	39	175	17.5	67	d
Total	383			1001
Patient’s delay, daysa							0.013
1–7	60	41.7	31	249	54.1	206	d
8–14	30	20.8	16	92	20.0	76	ns
15–21	11	7.6	6	34	7.4	28	ns
22–28	5	3.5	3	19	4.1	16	ns
>28	38	26.4	20	66	14.3	55	d
Total	144			460
Doctor’s delay, daysb							<0.001
0	322	83.9	123	848	92.6	700	d
1–7	19	4.9	7	21	2.3	17	d
8–14	6	1.6	2	7	0.8	6	ns
15–21	4	1.0	2	5	0.5	4	ns
22–28	5	1.3	2	2	0.2	2	d
>28	28	7.3	11	33	3.6	27	d
Total	384			916
Doctor’s delayb							0.001
1st contact	326	84.9	125	846	92.3	699	d
2nd contact	25	6.5	10	32	3.5	26	d
3rd contact	10	2.6	4	18	2.0	15	ns
4th contact	7	1.8	3	8	0.9	7	ns
5th contact	8	2.1	3	4	0.4	3	d
>5 contacts	8	2.1	3	9	1.0	7	ns
Total	384			917
Total duration of carec							<0.001
0–7 days (1 week)	225	58.6	86	465	50.6	384	d
8–30 days (1 month)	47	12.2	18	105	11.4	87	ns
31–60 days (2 months)	33	8.6	13	96	10.4	79	ns
61–90 days (3 months)	16	4.2	6	75	8.2	62	d
91–120 days (4 months)	5	1.3	2	43	4.7	36	d
121–150 days (5 months)	10	2.6	4	33	3.6	27	ns
151–180 days (6 months)	4	1.0	2	26	2.8	21	ns
>180 days (>6 months)	44	11.5	17	76	8.3	63	ns
Total	384			919

^aPatient delay data have been registered from 2016 onwards. ^bOnly patients with scabies diagnosis code S72 were included. ^cEpisodes included based on medication prescription only were excluded from analysis, ^dPost-hoc analyses indicate that the difference between the two periods for a specific category is significant at P<0.05; whereas ns indicates a non-significant difference between the two periods (Bonferroni adjusted)